Vongbhavit, Kannikar
Salinero, Lauren K.
Kalanetra, Karen M.
Masarweh, Chad
Yu, Alice
Taft, Diana H.
Mills, David A.
Underwood, Mark A. https://orcid.org/0000-0001-7453-5022
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD093185)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (AT008759)
Article History
Received: 26 January 2022
Revised: 3 June 2022
Accepted: 27 June 2022
First Online: 15 July 2022
Competing interests
: DAM is a co-founder of Evolve Biosystems, a company focused on diet-based manipulation of the gut microbiota and BCD Biosciences, a company advancing novel bioactive glycans. Neither Evolve Biosystems nor BCD Biosciences had a role in the conceptualization, design, data collection, analysis, or preparation of this manuscript. None of the other authors have any potential competing interests.